TransMedics Group Inc 2022 SR
The report is TransMedics' inaugural ESG disclosure, detailing its mission to transform organ transplantation using the Organ Care System (OCS) platform. In 2022, the company expanded its workforce to 212 employees, with women comprising 50% of the U.S. staff and 37.5% of executive leadership. The report highlights the National OCS Program's role in increasing organ utilization and improving clinical outcomes. TransMedics maintains a robust Quality Management System certified to ISO 13485 and follows NIST CSF for cybersecurity. Environmental efforts focus on product lifecycle management, including reclaiming consoles and using recyclable packaging.
Company: TransMedics Group Inc
Sector: Health Care
Country: United States
Year: 2022
Type: SR
Pages: 32
TransMedics Group Inc
ESG Report
The report is TransMedics' inaugural ESG disclosure, detailing its mission to transform organ transplantation using the Organ Care System (OCS) platform. In 2022, the company expanded its workforce to 212 employees, with women comprising 50% of the U.S. staff and 37.5% of executive leadership. The report highlights the National OCS Program's role in increasing organ utilization and improving clinical outcomes. TransMedics maintains a robust Quality Management System certified to ISO 13485 and follows NIST CSF for cybersecurity. Environmental efforts focus on product lifecycle management, including reclaiming consoles and using recyclable packaging.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Jan 1, 2020 - Dec 31, 2022
Fiscal Year
2022
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Women in Management
Employees